<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>L52SER_C</title>
    <meta name="title" content="NHANES 2003-2004: Human Papillomavirus (HPV) - 6, 11, 16 &amp; 18 Antibody - Serum: 4-plex CLIA Data Documentation, Codebook, and Frequencies" />
    <style type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					margin: 0 3em 1em;
					padding: 0;
					text-align: left;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					.nhanes-doc li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</style>
    <style type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</style>
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXS06MK">LBXS06MK - HPV 06 (Merck competitive Luminex assay)</a>
              </li>
              <li>
                <a href="#LBXS11MK">LBXS11MK - HPV 11 (Merck competitive Luminex assay)</a>
              </li>
              <li>
                <a href="#LBXS16MK">LBXS16MK - HPV 16 (Merck competitive Luminex assay)</a>
              </li>
              <li>
                <a href="#LBXS18MK">LBXS18MK - HPV 18 (Merck competitive Luminex assay)</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2003-2004 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Human Papillomavirus (HPV) - 6, 11, 16 &amp; 18 Antibody - Serum: 4-plex CLIA (L52SER_C)</h3>
        <h4> Data File: L52SER_C.xpt</h4>
        <h5 class="left">First Published: December 2008</h5>
        <h5 class="right">Last Revised: NA</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p>Human
papillomavirus (HPV) infection is one of the most common sexually transmitted
infections in the United States. Cervical infection with certain types of HPV
is a major risk factor for cervical cancer in women. No national surveillance
system exists to measure the full burden of HPV infection, and no reliable
national population estimate of HPV exists. NHANES offers a unique opportunity
to assess the prevalence of HPV infection in the general population. </p>
<p>Reducing the
prevalence of HPV infection is a Developmental Healthy People 2010 objective:
&ldquo;Reducing the number of new HPV cases can help minimize the overall number of
cases of high risk subtypes associated with cervical cancer in females ...&rdquo; An
HPV vaccine has been licensed, and knowledge of the national prevalence of HPV
infection is critical for planning vaccination strategies and monitoring the
impact of vaccination in the United States.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p>All participants aged 18 to 59 years were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p><b>Multiplex Luminex
Assay of Antibodies to Neutralizing Epitopes on HPV 6, 11, 16 and 18
L1-Virus-Like Particles (VLPs)</b> </p>
<p>This method uses
the Luminex platform to simultaneously assay antibodies to HPV 6, 11, 16 and
18. Type-specific antibodies of any Ig class are detected by displacement of
fluorescently tagged neutralizing monoclonal antibody from VLP-coated
microspheres.</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2003-2004/labmethods/L52SER_C_MET.pdf">HPV Serum 4-Multiplex Luminex Laboratory Procedure Manual</a>
          <span> (November 2018)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p>Serum samples were
processed, stored and shipped to the Chronic Viral Diseases Branch, Division of
High-Consequence Pathogens and Pathology, National Center for Emerging and
Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta,
GA for analysis. </p>
<p>Detailed
instructions on specimen collection and processing are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2003-2004/manuals/lab.pdf">NHANES
Laboratory Procedures Manual (LPM)</a>. Serum were stored under
appropriate frozen conditions (-20&deg;C) until they were shipped to the National
Center for Emerging and Zoonotic Infectious Diseases for testing.</p>
<p>The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory
Improvement Act mandates. Detailed QA/QC instructions are discussed in the
NHANES <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2003-2004/manuals/lab.pdf">LPM</a>.</p>
<p><b>Mobile Examination
Centers (MECs)</b></p>
<p>Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured competency assessment evaluation during visits to
evaluate both the quality of the laboratory work and the quality-control
procedures. Each laboratory staff member is observed for equipment operation,
specimen collection and preparation; testing procedures and constructive
feedback are given to each staff member. Formal retraining sessions are
conducted annually to ensure that required skill levels were maintained.</p>
<p><b>Analytical
Laboratories</b></p>
<p>NHANES uses
several methods to monitor the quality of the analyses performed by the
contract laboratories. In the MEC, these methods include performing blind split
samples collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories
randomly perform repeat testing on 2% of all specimens.</p>
<p>
Progress
reports containing any problems encountered during shipping or receipt of
specimens, summary statistics for each control pool, QC graphs, instrument
calibration, reagents, and any special considerations are submitted to NCHS
quarterly. The reports are reviewed for trends or shifts in the data. The
laboratories are required to explain any identified areas of concern.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p>The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p>Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2003">2003-2004
Laboratory Data Overview</a>&nbsp;for general information on NHANES laboratory
data.</p>
<p><b>Sample Weights</b></p>
<p>MEC exam sample
weights should be used for analyses.</p>
<p><b>Demographic and
Other Related Variables</b></p>
<p>The analysis of
NHANES laboratory data must be conducted using the appropriate survey design
and demographic variables. The NHANES <a href="https://wwwn.cdc.gov/Nchs/Nhanes/2003-2004/DEMO_C.XPT">2003-2004
Demographics File</a> contains demographic data, health indicators, and
other related information collected during household interviews as well as the
sample design variables. The recommended procedure for variance estimation
requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively)
in the demographic data file.</p>
<p>This laboratory
data file can be linked to the other NHANES data files using the unique survey
participant identifier (i.e., SEQN).</p>
<p>The Questionnaire
data files contain socio-economic data, health indicators, and other related
information collected during household interviews. Certain sensitive data on participants
under 18 years of age (e.g., HPV typing results, sexual behavior variables) are
not included in the public use files. These data may be requested as described
in the NHANES guidelines.</p>
<p><b>Detection Limits</b></p>
<p>If data is qualitative, the use of lower limits of
detection (LLODs) is not applicable. </p>
<p>Please refer to
the <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">NHANES Analytic
Guidelines</a> and the on-line NHANES <a href="https://www.cdc.gov/nchs/tutorials/">Tutorial</a> for further
details on the use of sample weights and other analytic issues. </p>
<p><b>Serology Assay</b> </p>
<p>
Competitive
Luminex Assay for HPV 6, 11, 16, 18: Merck established the serostatus cut-off
values for a positive result for each HPV type in the assay.<br />
</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>Dias D,Van Doren J, Schlottmann S, KellyS, Puchalski D, Ruiz W, Boerckel P, Kessler J, Antonello J, Green T, Brown M, Smith J, Chirmule N, Barr E, Jansen KU, Esser MT. Optimization and Validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diag Lab Immunol 12:959-969, 2005.</li>
          <li>Opalka D, Lachman CE, MacMullen SA, Jansen KU, Smith JF, Chirmule N, Esser MT. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 10:108-115, 2003.</li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number.</dd>
            <dt>Target: </dt>
            <dd> Both males and females 18 YEARS -
			59 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXS06MK">LBXS06MK - HPV 06 (Merck competitive Luminex assay)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXS06MK</dd>
            <dt>SAS Label: </dt>
            <dd>HPV 06 (Merck competitive Luminex assay)</dd>
            <dt>English Text: </dt>
            <dd class="info">HPV 06 (Merck competitive Luminex assay)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 18 YEARS -
			59 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">417</td>
                <td class="values" align="right">417</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">2875</td>
                <td class="values" align="right">3292</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">261</td>
                <td class="values" align="right">3553</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXS11MK">LBXS11MK - HPV 11 (Merck competitive Luminex assay)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXS11MK</dd>
            <dt>SAS Label: </dt>
            <dd>HPV 11 (Merck competitive Luminex assay)</dd>
            <dt>English Text: </dt>
            <dd class="info">HPV 11 (Merck competitive Luminex assay)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 18 YEARS -
			59 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">151</td>
                <td class="values" align="right">151</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">3141</td>
                <td class="values" align="right">3292</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">261</td>
                <td class="values" align="right">3553</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXS16MK">LBXS16MK - HPV 16 (Merck competitive Luminex assay)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXS16MK</dd>
            <dt>SAS Label: </dt>
            <dd>HPV 16 (Merck competitive Luminex assay)</dd>
            <dt>English Text: </dt>
            <dd class="info">HPV 16 (Merck competitive Luminex assay)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 18 YEARS -
			59 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">338</td>
                <td class="values" align="right">338</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">2954</td>
                <td class="values" align="right">3292</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">261</td>
                <td class="values" align="right">3553</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXS18MK">LBXS18MK - HPV 18 (Merck competitive Luminex assay)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXS18MK</dd>
            <dt>SAS Label: </dt>
            <dd>HPV 18 (Merck competitive Luminex assay)</dd>
            <dt>English Text: </dt>
            <dd class="info">HPV 18 (Merck competitive Luminex assay)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 18 YEARS -
			59 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">145</td>
                <td class="values" align="right">145</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">3147</td>
                <td class="values" align="right">3292</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">261</td>
                <td class="values" align="right">3553</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>